Bill Summary

SB 1602 Cancer Clinical Trials (2019 Session)
Cancer Clinical Trials; Requiring cancer clinical trial programs to inform prospective patient subjects of the specified reimbursements for ancillary costs and travel expenses which may be available to them and their caregivers if they participate in a cancer clinical trial; specifying that reimbursement offers may not be coercive or exert an undue influence and are not considered inducements for participation; requiring certain entities that offer reimbursement programs to secure the informed consent of patient subjects, etc. Effective Date: 7/1/2019
03/01/19
SENATE
Filed
03/08/19
SENATE
Referred to Health Policy; Banking and Insurance; Rules
05/03/19
SENATE
Indefinitely postponed and withdrawn from consideration
05/03/19
SENATE
Died in Health Policy
1602
Filed on 03/01/19
PDF
No amendments to this bill text filed.
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.

No reports related to this bill.

Upcoming Events
Florida's most comprehensive legislative calendar. Learn more.

No events are scheduled at this time.

Press Releases
Related Press Announcements. Learn more.

No press releases related to this bill.

Features above are available to LobbyTools subscribers. Request a free demo or call (850) 915-0100 ext. 2 to learn more.